Definitive Contract 00261200107D261017121

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Patheon API Services, Inc. (doing business as Irix) on February 2, 2012. The contract, valued at $89,900.00, requires the production of 8 kilograms of SGS742 under current good manufacturing practice (CGMP) conditions. The contract has no set-aside designation and is scheduled for completion on April 15, 2012. Patheon API Services, Inc. is the prime contractor, and there is...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to On Demand Pharmaceuticals Inc. The contract is for the development of small manufacturing systems to produce research-grade pharmaceutical intermediates, under SBIR Topic 024. The contract is a firm-fixed-price definitive contract with a ceiling value of $325,000.00 and an ultimate completion date...

This is a firm-fixed-price purchase order contract awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools located in Ann Arbor, Michigan. The $95,690.00 contract is for the purchase of 14 chemical substances to support the DEA's pharmacology testing and abuse potential evaluation efforts. The substances, which include compounds such as ortho methylfentanyl and Fluetonitazene, are required in varying...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $581,604 firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, to acquire approximately 2-3 kilograms of cGMP-grade GS-441524 for potential treatment of COVID-19. The award is pursuant to a combined synopsis/solicitation seeking this same cGMP material from Avista, as they are currently producing non-cGMP GS-441524 under...

This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract, valued at $128,000.00, is for the synthesis of 2R,6R-hydroxynorketamine hydrochloride. The contract is a firm fixed price purchase order with a completion date of January 21, 2017. The contract does not have a set-aside designation. Wuxi Apptec (Hongkong) LIMITED is a global contract research and development...

The National Institute on Drug Abuse (NIDA) awarded a $7,831,331.48 cost-plus-fixed-fee contract to Murty Pharmaceuticals, Inc., a minority-owned small disadvantaged business, for the development and manufacturing of pharmaceutical products to treat substance abuse disorders. The 5-year contract, which runs from September 18, 2016 to September 17, 2021, includes the production of morphine sulfate pellets and methamphetamine hydrochloride in support of NIDA's efforts to develop new medications...

This federal contract award, valued at $77,189.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services. The contract was awarded to Toronto Research Chemicals Inc., a for-profit organization that provides chemical compounds, reference materials, and other analytical products to federal agencies. The contract is for the provision of a "CHEMICAL LIBRARY FOR NCATS/TORONTO RESEARCH CHEMICALS" and does not utilize...

The National Institute of Child Health and Human Development (NICHD) awarded a $8,100,889.00 definitive contract to the Regents of the University of Minnesota, doing business as Office Sponsored Projects Administration, to operate a Chemical Synthesis Facility. The purpose of the facility is to synthesize and purify chemicals, chemical intermediates, drugs, steroids, and anti-fertility agents for further contraceptive development by the government. The contract has a 7-year period of performance...

This federal contract award, valued at $14,760.00, was issued by the Department of Health and Human Services (HHS) to American Biochemicals Inc., a minority-owned small disadvantaged business, for the custom synthesis and purification of the organic compound (2,2-DIMETHYL-2H-CHROMEN-5-YL) METHANOL. The contract was issued on a firm fixed-price basis and does not utilize a set-aside designation. American Biochemicals Inc. has previously provided specialized synthesis services to HHS agencies,...